Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Connector enhancer of kinase suppressor of ras 3 (CNKSR3) is a scaffold/adaptor protein primarily involved in the regulation of epithelial sodium channel (ENaC)-mediated sodium transport and aldosterone-induced responses in various tissues, particularly the kidney. CNKSR3 acts as a molecular scaffold to coordinate the assembly of multiprotein complexes regulating sodium transport across epithelial membranes, contributing to the maintenance of sodium balance and blood pressure. It also negatively regulates the ERK1/2 signaling pathway and modulates peptidyl-serine phosphorylation. Mutations or altered expression of CNKSR3 have been associated with rare conditions such as immunodeficiency 40 and xanthinuria. Currently, no drugs are known to interact directly with CNKSR3, and it is not used as a biomarker or implicated in direct safety concerns in therapeutic settings
Not applicable; no drugs currently reported to target CNKSR3 directly; its role is in protein scaffolding and regulation of other proteins (especially ENaC)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Connector enhancer of kinase suppressor of ras 3 (CNKSR3).